These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 932641

  • 1. Genetic control of specific immune suppression. III. Mapping of H-2 complex complementing genes controlling immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT).
    Debré P, Waltenbaugh C, Dorf M, Benacerraf B.
    J Exp Med; 1976 Jul 01; 144(1):272-6. PubMed ID: 932641
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT) II. Presence of I-J determinants on the GT-suppressive factor.
    Thèze J, Waltenbaugh C, Dorf ME, Benacerraf B.
    J Exp Med; 1977 Jul 01; 146(1):287-92. PubMed ID: 68991
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the cross-reactive immune suppression induced by the random copolymers L-glutamic acid50-L-tyrosine50 (GT), L-glutamic acid60-L-alanine40 and L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT).
    Waltenbaugh C, Debré P, Benacerraf B.
    J Immunol; 1976 Nov 01; 117(5 Pt 1):1603-7. PubMed ID: 1002991
    [Abstract] [Full Text] [Related]

  • 4. In vivo effects of anti-Ia alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants.
    Pierres M, Germain RN, Dorf ME, Benacerraf B.
    J Exp Med; 1978 Mar 01; 147(3):656-66. PubMed ID: 75939
    [Abstract] [Full Text] [Related]

  • 5. Genetic control of specific immune suppression. II. H-2-linked dominant genetic control of immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT).
    Debré P, Kapp JA, Dorf ME, Benacerraf B.
    J Exp Med; 1975 Dec 01; 142(6):1447-54. PubMed ID: 1194855
    [Abstract] [Full Text] [Related]

  • 6. Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.
    Debré P, Waltenbaugh C, Dorf ME, Benacerraf B.
    J Exp Med; 1976 Jul 01; 144(1):277-81. PubMed ID: 1084407
    [Abstract] [Full Text] [Related]

  • 7. Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice.
    Debré P, Kapp JA, Benacerraf B.
    J Exp Med; 1975 Dec 01; 142(6):1436-46. PubMed ID: 1104746
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT). III. Generation of suppressor T cells by a suppressive extract derived from GT-primed lymphoid cells.
    Waltenbaugh C, Thèze J, Kapp JA, Benacerraf B.
    J Exp Med; 1977 Oct 01; 146(4):970-85. PubMed ID: 302317
    [Abstract] [Full Text] [Related]

  • 9. Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.
    Kapp JA, Pierce CW, Benacerraf B.
    J Exp Med; 1973 Nov 01; 138(5):1107-20. PubMed ID: 4126766
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antigen-specific T-cell-mediated suppression. I. Induction of L-glutamic acid60-L-alanine30-L-tyrosine10 specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen.
    Germain RN, Thèze J, Kapp JA, Benacerraf B.
    J Exp Med; 1978 Jan 01; 147(1):123-36. PubMed ID: 75231
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT). I. Production, characterization, and lack of H-2 restriction for activity in recipient strain.
    Waltenbaugh C, Debré P, Thèze J, Benacerraf B.
    J Immunol; 1977 Jun 01; 118(6):2073-7. PubMed ID: 68079
    [Abstract] [Full Text] [Related]

  • 13. Genetic control of immune responses in vitro. II. Cellular requirements for the development of primary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.
    Kapp JA, Pierce CW, Benacerraf B.
    J Exp Med; 1973 Nov 01; 138(5):1121-32. PubMed ID: 4126767
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antigen-specific suppressor T cell interactions. I. Induction of an MHC-restricted suppressor factor specific for L-glutamic acid50-L-tyrosine50.
    Kapp JA, Araneo BA.
    J Immunol; 1982 Jun 01; 128(6):2447-52. PubMed ID: 6176635
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) II. Cellular source and effect on responder and nonresponder mice.
    Kapp JA, Pierce CW, Benacerraf B.
    J Exp Med; 1977 Apr 01; 145(4):828-38. PubMed ID: 300776
    [Abstract] [Full Text] [Related]

  • 20. Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice.
    Kapp JA, Pierce CW, Benacerraf B.
    J Exp Med; 1974 Jul 01; 140(1):172-84. PubMed ID: 4857865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.